|
HY-P77091-10ug
|
MedChemexpress LLC
|
Mu CL1, Human (HEK293, His)
|
|
|
|
|
HY-P77091-5ug
|
MedChemexpress LLC
|
Mu CL1, Human (HEK293, His)
|
|
|
|
|
HY-B1703-100mg
|
MedChemexpress LLC
|
Nifursol [CAS 16915-70-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-B1703-500mg
|
MedChemexpress LLC
|
Nifursol [CAS 16915-70-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-B1703-1mL
|
MedChemexpress LLC
|
Nifursol [CAS 16915-70-1] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-B1703S-1mg
|
MedChemexpress LLC
|
Nifursol-13C6
|
|
COVID-19-immunoregulation
|
|
|
HY-129065-10mg
|
MedChemexpress LLC
|
Nourseothricin (sulfate) [CAS 96736-11-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-129065-5mg
|
MedChemexpress LLC
|
Nourseothricin (sulfate) [CAS 96736-11-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-129065-50mg
|
MedChemexpress LLC
|
Nourseothricin (sulfate) [CAS 96736-11-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-129065-1mL
|
MedChemexpress LLC
|
Nourseothricin (sulfate) [CAS 96736-11-7] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-P73736-10ug
|
MedChemexpress LLC
|
Olfactory Marker/OMP, Human (His)
|
|
|
|
|
HY-P73736-100ug
|
MedChemexpress LLC
|
Olfactory Marker/OMP, Human (His)
|
|
|
|
|
HY-P73736-5ug
|
MedChemexpress LLC
|
Olfactory Marker/OMP, Human (His)
|
|
|
|
|
HY-P73736-50ug
|
MedChemexpress LLC
|
Olfactory Marker/OMP, Human (His)
|
|
|
|
|
HY-P71180-1mg
|
MedChemexpress LLC
|
OLR1, Human (HEK293, His)
|
|
|
|
|
HY-P71180-10ug
|
MedChemexpress LLC
|
OLR1, Human (HEK293, His)
|
|
|
|
|
HY-P71180-100ug
|
MedChemexpress LLC
|
OLR1, Human (HEK293, His)
|
|
|
|
|
HY-P71180-5ug
|
MedChemexpress LLC
|
OLR1, Human (HEK293, His)
|
|
|
|
|
HY-P71180-50ug
|
MedChemexpress LLC
|
OLR1, Human (HEK293, His)
|
|
|
|
|
HY-P71180-500ug
|
MedChemexpress LLC
|
OLR1, Human (HEK293, His)
|
|
|
|
|
HY-N0157-100mg
|
MedChemexpress LLC
|
Orotic acid [CAS 65-86-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-N0157-500mg
|
MedChemexpress LLC
|
Orotic acid [CAS 65-86-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-N0157-1mL
|
MedChemexpress LLC
|
Orotic acid [CAS 65-86-1] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-W110929-100mg
|
MedChemexpress LLC
|
Patent Blue V [CAS 129-17-9]
|
|
Cancer-programmed cell death
|
|
|
HY-W110929-500mg
|
MedChemexpress LLC
|
Patent Blue V [CAS 129-17-9]
|
|
Cancer-programmed cell death
|
|
